-
Reduced Pain and Improved Function Following Short-Term Use of Noninvasive BioWave High Frequency Peripheral Nerve Stimulation for Pain Management
Alaa Abd-Elsayed, Michael Gyorfi, Michael Fischman, Charles Odonkor, Bradford Siff, Kevin Cyr.
Open-label survey of chronic pain patients recruited from Veteran Affairs, orthopedic and pain health systems. This retrospective pilot study is shaped around a noninvasive…
-
An Open-Label Pilot Study Investigating Noninvasive High-Frequency Peripheral Nerve Fiber Stimulation in Chronic Pain
D.A. Hegarty, B. Bretherton. Pain Management and Neuromodulation, Mater Private Hospital, Cork; Department of Anesthesiology, School of Medicine, University College, Cork, Ireland; School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds; Pain Management Department, Leeds Teaching Hospitals NHS Trust, Leeds, UK
-
Significantly Reduced Pain and Improved Function Following Short-Term Use of the BioWaveHOME High Frequency Neurostimulation System for Conservative Pain Management
Lindsay Kleinwaks, Ph.D., Senior Associate, Regulatory Affairs Dave McGurl, Director, Regulatory Affairs.
Following two weeks of BioWaveHOME use, four hundred sixty three (463) subjects provided responses via returned surveys. The BioWaveHOME device provided subjects with statistically…
-
Long Term Use of BioWaveHOME for the Treatment of Chronic Pain in Veterans
L. Kleinwaks, M. Rogers, D. McGurl
DISCLAIMER: This White Paper contains additional clinical information regarding BioWave and is provided for informational purposes only. Musculoskeletal Clinical Regulatory Advisors, LLC (MCRA), an…
-
Neuromodulation Pain Therapy Treatment
R. Yacoub
Neuromodulation pain therapy.
-
A Randomized Placebo-Controlled Study To Determine Safety and Efficacy In Terms Of Pain Reduction, Increased Range Of Motion, And Reduced Pain Medications, For A Novel Percutaneous Neuromodulation Pain Therapy Device (“BioWavePRO® with Deepwave® Percutaneous Electrode Arrays”) Following Post-Operative Treatments For Total Knee Replacement Procedures.
T. Wanich, J. Gelber, R. Windsor, S. Rodeo.
A randomized controlled pilot study to determine average maximum intensity settings, safety, and initial efficacy in terms of pain reduction, increased range of motion,…
-
Prospective Randomized Single-blinded Controlled Clinical Trial of Percutaneous Neuromodulation Pain Therapy Device Versus Sham for the Osteoarthritic Knee: A Pilot Study
Brian J. Cole, MD, MBA; Richard Kang, MD, MS; Paul B. Lewis, MD, MS; Adam Kramer, ATC; Jennifer K. Hayden, RN, MSN;
Randomized Single-blinded Controlled Clinical Trial of a BiowavePENS device (Percutaneous Electrical Nerve Stimulation) versus Sham PENS treatment for the Osteoarthritic Knee.
-
Treatment of pain from acute sports injuries using BioWavePRO
S. Panchal, J. Pergolizzi
White Paper on use of a neuromodulation pain therapy device (“BioWavePRO”) to treat acute sports injuries on New York Giants football players. 600 treatments…
-
Treatment of joint pain using BioWaveHOME
W. Coren
A clinical study of the efficacy of the BioWave home device for reducing pain and increasing range of motion over 24 hours following a…
-
Evaluation of optimal signal frequency and efficacy of BioWave
S. Diwan, H.C. Hemmings, R.F. Eliazo, S. Panchal
Symptomatic treatment of chronic low back pain: determination of optimal signal frequency and preliminary efficacy of a targeted noninvasive electronic pain control device.
Clinical Studies & White Papers
Explore the clinical evidence behind BioWave. Published studies consistently show meaningful pain reduction, improved function, and decreased medication use in both clinic and home settings. Review published studies, abstracts, white papers, and outcomes data that demonstrate how BioWave supports better results for complex patient populations.